InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · INM · as of Dec 31, 2024
Ownership Breakdown
1
Institutional Holders
▼ 11 vs Q3
$5
Total Inst. Value
▼ $265,978 vs Q3
1.81M
Shares Outstanding
freeFloat 99.61%
27
13F Shares Held
▼ 1.14M vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
INM largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 27 | 0.00% | 0.00% | $5,000 | Feb 7, 2025 | — held |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 13, 2025 | EXIT |
CITADEL ADVISORS LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2025 | EXIT |
ADVISORSHARES INVESTMENTS LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2025 | EXIT |
HRT FINANCIAL LP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2025 | EXIT |
VIRTU FINANCIAL LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 11, 2025 | EXIT |
BAADER BANK AKTIENGESELLSCHAFT pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Jan 23, 2025 | EXIT |
UBS GROUP AG pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2025 | EXIT |
ALLSQUARE WEALTH MANAGEMENT LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 11, 2025 | EXIT |
GLOBAL RETIREMENT PARTNERS, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Jan 31, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares11
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-11
0 new / 11 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
INM insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
ADAR1 Capital Management, LLC 10 percent owner | May 19, 2026 | Purchase | 200,000 | $1.50 | $299.8K | 800.0K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 19, 2026 | Purchase | 200,000 | $1.56 | $312.1K | 600.0K | Form 4 ↗ |
ADAR1 Capital Management, LLC 10 percent owner | May 19, 2026 | Purchase | 68,551 | $1.60 | $109.7K | 400.0K | Form 4 ↗ |
Johnson Shane Aaron Sr VP & General Manager | Dec 19, 2025 | Award | 8,500 | $1.29 | $11.0K | 12.4K | Form 4 ↗ |
Lemerond Nicole director | Dec 19, 2025 | Award | 1,750 | $1.29 | $2.3K | 2.7K | Form 4 ↗ |
Klompas Neil A director | Dec 19, 2025 | Award | 1,750 | $1.29 | $2.3K | 5.3K | Form 4 ↗ |
Jagpal Netta Chief Financial Officer | Dec 19, 2025 | Award | 18,000 | $1.29 | $23.2K | 24.3K | Form 4 ↗ |
WOUDENBERG MICHAEL Chief Operating Officer | Dec 19, 2025 | Award | 18,000 | $1.29 | $23.2K | 25.4K | Form 4 ↗ |
Bathery John Steven director | Dec 19, 2025 | Award | 1,750 | $1.29 | $2.3K | 5.3K | Form 4 ↗ |
HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Dec 19, 2025 | Award | 13,000 | $1.29 | $16.8K | 18.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
InMed Pharmaceuticals Inc. (INM) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 0.39%, while retail and public investors account for the remaining 99.61%.
The largest institutional shareholder of InMed Pharmaceuticals Inc. is ADVISOR GROUP HOLDINGS, INC., holding approximately 27 shares — equal to — of outstanding shares — as of December 31, 2024.
A total of 1 institutional investors currently hold INM stock, with a combined institutional value of approximately $5 as of the most recent 13F filing period.
Frequently asked questions
INM ownershipInMed Pharmaceuticals Inc. (INM) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is ADVISOR GROUP HOLDINGS, INC. with a — stake. Company insiders hold 0.39%. Data sourced from SEC Form 13F as of December 31, 2024.